Cancer Research The Future of Cancer Research: Science and Patient Impact  09 AM Call for Abstracts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 55, 4220-4224, October 1, 1995]
© 1995 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Beverloo, H. B.
Right arrow Articles by Berger, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Beverloo, H. B.
Right arrow Articles by Berger, R.

Breakpoint Heterogeneity in t(10;11) Translocation in AML-M4/M5 Resulting in Fusion of AF10 and MLL Is Resolved by Fluorescent in Situ Hybridization Analysis1

H. Berna Beverloo2, Maryvonne Le Coniat, Jacqueline Wijsman, Debra M. Lillington, Olivier Bernard, Annelies de Klein, Elisabeth van Wering, Jeanna Welborn, Bryan D. Young, Anne Hagemeijer and Roland Berger

Erasmus University, Department of Cell Biology and Genetics, P. O. Box 1738, 3000 DR Rotterdam, the Netherlands [H. B. B., J. W., A. d. K., A. H.]; Unite INSERM U 301, Institut de Genetique Moleculaire, 27 Rue Juliette Dodu, 75010 Paris, France [M. L. C., O. B., R. B.]; Imperial Cancer Research Fund, Department of Medical Oncology, St. Bartholomew's Hospital Medical College, London EC1M 6BQ, United Kingdom [D. M. L., B. D. Y.]; Dutch Childhood Leukemia Study Group, Leyweg 299, 2545 CJ The Hague, the Netherlands [E. v. W.]; and University of California, University of California Davis Medical Center, Hematology and Oncology, Sacramento, California 95816 [J. W.]

Ten AML-M4/M5 patients' samples containing a t(10;11) translocation, but with different cytogenetic breakpoints on chromosome 11q (11q13–23), were studied by G- and R-banding and fluorescent in situ hybridization. Southern blotting analysis, studied in five patients, revealed a rearranged MLL gene. Reverse transcription-PCR analysis carried out in six patients showed a 5' MLL-3' AF-10 fusion transcript. Fluorescent in situ hybridization studies suggested that in 8 of 10 patients, the rearrangement/fusion transcript resulted from an inversion of a part of 11q (q13q23) translocated to 10p12. In the other two patients, it is assumed that an inversion/translocation has occurred of a part of 10p to the der(11).

The results suggest that the orientation of the AF-10 gene on 10p is 5' telomeric and 3' centromeric. This is the first example of opposite-oriented genes being involved in translocation to yield fusion transcripts.

1 This study was supported by European Union Grant CT93-0055 (B. B.), European Union Grant CA CT94-1703 (A. H., B. D. Y., R. B.), by the Fondation contre la Leucemie, and by the Caroline Lawson Trust for Children's Cancer Research.

2 To whom requests for reprints should be addressed.

Received 7/11/95. Accepted 8/18/95.




This article has been cited by other articles:


Home page
BloodHome page
A. Reiter, J. Sohal, S. Kulkarni, A. Chase, D. H.C. Macdonald, R. C.T. Aguiar, C. Goncalves, J. M. Hernandez, B. A. Jennings, J. M. Goldman, et al.
Consistent Fusion of ZNF198 to the Fibroblast Growth Factor Receptor-1 in the t(8;13)(p11;q12) Myeloproliferative Syndrome
Blood, September 1, 1998; 92(5): 1735 - 1742.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
T. Taki, N. Shibuya, M. Taniwaki, R. Hanada, K. Morishita, F. Bessho, M. Yanagisawa, and Y. Hayashi
ABI-1, a Human Homolog to Mouse Abl-Interactor 1, Fuses the MLL Gene in Acute Myeloid Leukemia With t(10;11)(p11.2;q23)
Blood, August 15, 1998; 92(4): 1125 - 1130.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M.H. Dreyling, K. Schrader, C. Fonatsch, B. Schlegelberger, D. Haase, C. Schoch, W.-D. Ludwig, H. Loffler, T. Buchner, B. Wormann, et al.
MLL and CALM Are Fused to AF10 in Morphologically Distinct Subsets of Acute Leukemia With Translocation t(10;11): Both Rearrangements Are Associated With a Poor Prognosis
Blood, June 15, 1998; 91(12): 4662 - 4667.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1995 by the American Association for Cancer Research.